Cargando…
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
Hepatitis delta virus (HDV) is a small defective virus that needs hepatitis B virus (HBV) to replicate and propagate. HDV infection affects 20-40 million people worldwide and pegylated interferon (PegIFN) is the only recommended therapy. There is limited data on the contribution of HDV infection to...
Autores principales: | Puigvehí, Marc, Moctezuma-Velázquez, Carlos, Villanueva, Augusto, Llovet, Josep M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001537/ https://www.ncbi.nlm.nih.gov/pubmed/32039360 http://dx.doi.org/10.1016/j.jhepr.2019.05.001 |
Ejemplares similares
-
Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B
por: Moctezuma-Velázquez, Carlos, et al.
Publicado: (2021) -
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
por: Llovet, Josep M., et al.
Publicado: (2022) -
Infection by Hepatitis Delta Virus
por: Taylor, John M.
Publicado: (2020) -
The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
por: Labgaa, Ismail, et al.
Publicado: (2021) -
Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma
por: Hibner, Urszula, et al.
Publicado: (2015)